Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase Ib Clinical Study of AC-003 Capsules in Subjects With aGVHD.

The study was an open-label, single-arm, dose-escalation, Phase Ib, multi-center study to investigate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of AC-003 in patients with grade II-IV SR-aGVHD.

Participants needed: 24
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Accro Bioscience (Suzhou) LimitedUpdated: Mar 16, 2026Locations: 1
Eligibility criteria

Male or female patients age ≥ 18 years. [+6]

Evidence of aGVHD relapsed. [+6]

Read more
Status: Recruiting

A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of AC-101 tablets in participants with moderate-to-severe ulcerative colitis. The total study duration is up to 17 weeks, including 4-week screening, 12-week treatment period, and 1-week safety follow-up. The study will enroll approximately 24 participants with moderate to severe active ulcerative colitis.

Participants needed: 24
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Accro Bioscience (Suzhou) LimitedUpdated: Jul 24, 2025Locations: 1
Eligibility criteria

Diagnosis of Ulcerative Colitis (UC) or suspected UC symptom for at least 3 mont... [+6]

Previous/current documented diagnosis of Crohn's Disease (CD), indeterminate col... [+3]

Read more